Literature DB >> 7423582

Brain events associated with mitral valve prolapse.

M R Hanson, J P Conomy, J R Hodgman.   

Abstract

The clinical and laboratory features of 24 patients with proven mitral valve prolapse (MVP) and brain dysfunction are reported. The age range of affected patients was between 20 and 63 years (average of 43) and 70 percent were women. MVP was documented prior to the brain illness in only 4 patients. The majority of patients experienced bland cerebral infarction. Disorders also included transient ischemic attacks, cerebellar infarctions, parencymatous and subarachnoid hemorrhage, seizures and retinal artery occlusion. Significant risk factors for stroke other than MVP were lacking in the patient group. Cerebral angiograms occasionally showed distal occlusions of small arteries suggesting embolic brain lesions. Our study suggests that MVP is a risk factor for stroke. We recommend echocardiography in patients with cerebral ischemia who lack clear, recognized risk factors for stroke. We believe the basis for this brain disorder to be emboli from damaged mitral valve leaflets.

Entities:  

Mesh:

Year:  1980        PMID: 7423582     DOI: 10.1161/01.str.11.5.499

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  5 in total

1.  Internal carotid artery occlusion in a young female with mitral valve prolapse.

Authors:  M A Saadah; R A Shakir; M A Rudwan; N Khan
Journal:  Postgrad Med J       Date:  1986-12       Impact factor: 2.401

2.  Stroke in young people--the heart of the matter.

Authors:  R G Hart; G L Freeman
Journal:  West J Med       Date:  1987-05

Review 3.  Risk factors in stroke.

Authors:  P Mustacchi
Journal:  West J Med       Date:  1985-08

4.  Brain infarction and hemorrhage in young and middle-aged adults.

Authors:  J R Lacy; C M Filley; M P Earnest; N R Graff-Radford
Journal:  West J Med       Date:  1984-09

5.  Increased prevalence of mitral valve prolapse in patients with migraine.

Authors:  J D Spence; D G Wong; L J Melendez; P M Nichol; J D Brown
Journal:  Can Med Assoc J       Date:  1984-12-15       Impact factor: 8.262

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.